Showing results (251-260 of 297) with videos related to

Sort By:
Pageof 30
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Hepatology (Baltimore, Md.)|March 13, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case seriesChristopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feedingLina Jegodzinski, Lorena Rudolph, Darko Castven, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2025
Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis DToni Herta, Christopher Dietz-Fricke, Münevver Demir, et al.
Cells|December 23, 2022
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and AmidationMarta Alonso-Peña, Ricardo Espinosa-Escudero, Heike M Hermanns, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2019
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trialStefan Traussnigg, Jörn M Schattenberg, Münevver Demir, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal CohortNajib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Journal of Lipid Research|May 23, 2019
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitisTina Raselli, Tom Hearn, Annika Wyss, et al.
Pageof 30